Page 1 of Clinical Trials for Peginterferon alfa-2b, 258 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)(COMPLETED)
Last Updated: February 25, 2011
Condition(s): Hepatitis C, Chronic; Hepacivirus
2
Completed
Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC
Last Updated: February 13, 2012
Condition(s): Hepatitis C
3
Completed
Effect of Low-Dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)
Last Updated: November 6, 2008
Condition(s): Hepatitis C, Chronic; Hepatitis C
4
Terminated
PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Last Updated: May 16, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
5
Completed
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603AM3)(COMPLETED)
Last Updated: March 24, 2011
Condition(s): Hepatitis D, Chronic; Hepatitis B, Chronic
6
Completed
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548AM2)(COMPLETED)
Last Updated: April 8, 2010
Condition(s): Hepatitis C, Chronic
7
Completed
PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498)(COMPLETED)
Last Updated: November 18, 2010
Condition(s): Hepatitis B, Chronic (CHB)
8
Not yet recruiting
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)
Last Updated: May 1, 2012
Condition(s): Chronic Hepatitis C
9
Completed
Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690 AM1)(COMPLETED)
Last Updated: October 10, 2011
Condition(s): Hepatitis C, Chronic; Hepatitis C
10
Completed
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)(COMPLETED)
Last Updated: December 2, 2010
Condition(s): Hepatitis C, Chronic; Hepatitis C
11
Completed
Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471AM1)(COMPLETED)
Last Updated: April 4, 2011
Condition(s): Hepatitis C, Chronic
12
Terminated
PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron
Last Updated: July 1, 2009
Condition(s): Leukemia, Myeloid, Philadelphia-Positive
13
Completed
Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (Study P04408)(COMPLETED)
Last Updated: June 9, 2010
Condition(s): Hepatitis C, Chronic; Substance Abuse, Intravenous
14
Completed
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)
Last Updated: June 17, 2010
Condition(s): Hepatitis C, Chronic; Hepacivirus
15
Terminated
Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)(TERMINATED)
Last Updated: July 25, 2008
Condition(s): Hepatitis C, Chronic; Hepacivirus
16
Terminated
The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833AM2)(TERMINATED)
Last Updated: October 1, 2009
Condition(s): Hepatitis C, Chronic
17
Completed
Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)
Last Updated: October 4, 2011
Condition(s): Hepatitis C, Chronic; Hepatitis C
18
Completed
Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538AM1 Part 1)(COMPLETED)
Last Updated: October 13, 2009
Condition(s): Hepatitis C, Chronic
19
Terminated
Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)(TERMINATED)
Last Updated: December 2, 2009
Condition(s): Hepatitis C, Chronic
20
Terminated
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)
Last Updated: December 2, 2009
Condition(s): Hepatitis C, Chronic

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Peginterferon+alfa-2b

Page 1 of Clinical Trials for Peginterferon alfa-2b, 258 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About